Market Access Money vs mindset: How the NHS can make the most of extra inv... It was the day we’d all been waiting for. Rachel Reeves’ Autumn Budget felt like it had been on the horizon for a while.
News NHS under scrutiny amid worst-ever performance in cancer and... The performance of the NHS has come under the spotlight once again, following figures showing worst-ever performances against waiting times targets for cancer treatment and in A&E.
News Tax breaks could nurture UK’s cell and gene therapy manufact... Tax breaks for R&D and innovative manufacturing could be part of life sciences strategy.
News NHS set to lose out to Brexit in budget Brexit bill and debt levels make spending spree unlikely, says Chancellor
News UK MHRA green lights AbbVie’s ELAHERE for ovarian cancer AbbVie has secured UK marketing authorisation for ELAHERE (mirvetuximab soravtansine), the first antibo
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face